EQUETRO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Equetro, and what generic alternatives are available?
Equetro is a drug marketed by Validus Pharms and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.
This drug has one patent family member in one country.
The generic ingredient in EQUETRO is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Equetro
A generic version of EQUETRO was approved as carbamazepine by TARO on October 3rd, 1996.
Summary for EQUETRO
International Patents: | 1 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 163 |
Clinical Trials: | 4 |
Patent Applications: | 4,321 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EQUETRO |
What excipients (inactive ingredients) are in EQUETRO? | EQUETRO excipients list |
DailyMed Link: | EQUETRO at DailyMed |
Recent Clinical Trials for EQUETRO
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Validus Pharmaceuticals | Phase 4 |
Creighton University | Phase 4 |
Tuscaloosa Research & Education Advancement Corporation | Phase 4 |
Pharmacology for EQUETRO
Anatomical Therapeutic Chemical (ATC) Classes for EQUETRO
Paragraph IV (Patent) Challenges for EQUETRO
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
EQUETRO | Extended-release Capsules | carbamazepine | 100 mg | 021710 | 1 | 2014-05-23 |
EQUETRO | Extended-release Capsules | carbamazepine | 200 mg and 300 mg | 021710 | 1 | 2007-08-21 |
US Patents and Regulatory Information for EQUETRO
EQUETRO is protected by one US patents.
Patents protecting EQUETRO
Methods for the treatment of bipolar disorder using carbamazepine
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: THE RECOMMENDED INITIAL DOSE OF EQUETRO IS 400MG/DAY GIVEN IN DIVIDED DOSES, TWICE DAILY. THE DOSE SHOULD BE ADJUSTED IN 200MG DAILY INCREMENTS TO ACHIEVE OPTIMAL CLINICAL RESPONSE.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-001 | Dec 10, 2004 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-002 | Dec 10, 2004 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-003 | Dec 10, 2004 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for EQUETRO
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-003 | Dec 10, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-002 | Dec 10, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-001 | Dec 10, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-002 | Dec 10, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-003 | Dec 10, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-001 | Dec 10, 2004 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for EQUETRO
See the table below for patents covering EQUETRO around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2137948 | ⤷ Try a Trial | |
Austria | 185268 | ⤷ Try a Trial | |
Canada | 2452588 | METHODE DE TRAITEMENT DE TROUBLES AFFECTIFS BIPOLAIRES A L'AIDE DE CARBAMAZEPINE (METHODS FOR THE TREATMENT OF BIPOLAR DISORDER USING CARBAMAZEPINE) | ⤷ Try a Trial |
Japan | H06511484 | ⤷ Try a Trial | |
European Patent Office | 0660705 | SYSTEME ET METHODE PERFECTIONNES D'ADMINISTRATION DE MEDICAMENTS ET DE TRAITEMENT DES AFFECTIONS PSYCHIATRIQUES, NEUROLOGIQUES ET AUTRES AVEC LA CARBAMAZEPINE (ADVANCED DRUG DELIVERY SYSTEM AND METHOD OF TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISORDERS WITH CARBAMAZEPINE) | ⤷ Try a Trial |
Denmark | 0660705 | ⤷ Try a Trial | |
Greece | 3031448 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |